Right ventricular assist device with membrane oxygenator support for right ventricular failure following implantable left ventricular assist device placement

European Journal of Cardio-thoracic Surgery

Volumn 49, Issue 1, 2016, Pages 73-77

  Leidenfrost, Jeremy ^a   Prasad, Sunil ^a   Itoh, Akinobu ^a   Lawrance, Christopher P ^a   Bell, Jennifer M ^a   Silvestry, Scott C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Membrane oxygenation; Right ventricular failure; Ventricular assist device

Indexed keywords

HYPERTENSIVE FACTOR;

ADULT; ARTICLE; ASSISTED CIRCULATION; BLOOD PUMP; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE FAILURE; HOSPITAL DISCHARGE; HUMAN; INOTROPISM; MAJOR CLINICAL STUDY; MEMBRANE OXYGENATOR; MIDDLE AGED; MORTALITY RATE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RIGHT VENTRICULAR ASSIST DEVICE; SURVIVAL RATE; TIME TO TREATMENT; VESSEL DILATOR; AGED; DIAGNOSIS; FEMALE; FOLLOW UP; HEART ASSIST DEVICE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; MALE; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PROCEDURES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURGERY; SURVIVAL ANALYSIS; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AGED; COMBINED MODALITY THERAPY; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; FOLLOW-UP STUDIES; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; OXYGENATORS, MEMBRANE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84958660435     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezv116     Document Type: Article

References (25)

1. Loforte A, Montalto A, Lilla Della Monica P, Musumeci F. Simultaneous temporary CentriMag right ventricular assist device placement in HeartMate II left ventricular assist system recipients at high risk of right ventricular failure. Interact CardioVasc Thorac Surg 2010;10:847-50.
2. Scherer M, Sirat AS, Moritz A, Martens S. Extracorporeal membrane oxygenation as perioperative right ventricular support in patients with biventricular failure undergoing left ventricular assist device implantation. Eur J Cardiothorac Surg 2011;39:939-44.
3. Hoskote A, Carter C, Rees P, Elliott M, Burch M, Brown K. Acute right ventricular failure after pediatric cardiac transplant: predictors and long-term outcome in current era of transplantation medicine. J Thorac Cardiovasc Surg 2010;139:146-53.
4. Klima U, Ringes-Lichtenberg S, Warnecke G, Lichtenberg A, Strüber M, Haverich A. Severe right heart failure after heart transplantation. A singlecenter experience. Transpl Int 2005;18:326-32.
5. Moon MR, Castro LJ, DeAnda A, Tomizawa Y, Daughters GT, Ingels NB et al. Right ventricular dynamics during left ventricular assistance in closed-chest dogs. Ann Thorac Surg 1993;56:54-66; discussion 66-7.
6. Morgan JA, John R, Lee BJ, Oz MC, Naka Y. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg 2004;77:859-63.
7. Marquez TT, D'Cunha J, John R, Liao K, Joyce L. Mechanical support for acute right ventricular failure: evolving surgical paradigms. J Thorac Cardiovasc Surg 2009;137:e39-40.
8. Takeda K, Naka Y, Yang JA, Uriel N, Colombo PC, Jorde UP et al. Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion. J Heart Lung Transplant 2013;33:141-8.
9. Bartfay SE, Liden H, Holmberg M, Karason K, Gabel J, Selimovic N et al. The BiVAD experience at the university hospital, results from the years 2010 to 2012 and comparison with contemporary LVAD patients. Eur Heart J 2013;34:392.
10. Drakos SG, Janicki L, Horne BD, Kfoury GA, Reid BB, Clayson S et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol 2010;105:1030-5.
11. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008;51:2163-72.
12. Aissaoui N, Morshuis M, Schoenbrodt M, Hakim Meibodi K, Kizner L, Borgermann J et al. Temporary right ventricular mechanical circulatory support for the management of right ventricular failure in critically ill patients. J Thorac Cardiovasc Surg 2013;146:186-91.
13. Moazami N, Pasque MK, Moon MR, Herren R, Bailey M, Lawton JS et al. Mechanical support for isolated right ventricular failure in patients after cardiotomy. J Heart Lung Transplant 2004;23:1371-5.
14. Fitzpatrick JR III, Frederick JR, Hiesinger W, Hsu VM, McCormick RC, Kozin ED et al. Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J Thorac Cardiovasc Surg 2009;137:971-7.
15. Copeland JG, Smith RG, Bose RK, Tsau PH, Nolan PE, Slepian MJ. Risk factor analysis for bridge to transplantation with the CardioWest total artificial heart. Ann Thorac Surg 2008;85:1639-44.
16. Maxwell BG, Powers AJ, Sheikh AY, Lee PH, Lobato RL, Wong JK. Resource use trends in extracorporeal membrane oxygenation in adults: an analysis of the Nationwide Inpatient Sample 1998-2009. J Thorac Cardiovasc Surg 2013;31:416-21.e1.
17. Peek GJ, Killer HM, Reeves R, Sosnowski AW, Firmin RK. Early experience with a polymethyl pentene oxygenator for adult extracorporeal life support. ASAIO J 2002;48:480-2.
18. Khoshbin E, Roberts N, Harvey C, Machin D, Killer H, Peek GJ et al. Poly-methyl pentene oxygenators have improved gas exchange capability and reduced transfusion requirements in adult extracorporeal membrane oxygenation. ASAIO J 2005;51:281-7.
19. Granger E, Macdonald P, Spratt P, Jansz P, Hayward C, Soto C. ECMO for Acute Right Heart Failure. Heart Lung Circ 2011;20:35-67.
20. Morita K. Surgical reoxygenation injury of the myocardium in cyanotic patients: clinical relevance and therapeutic strategies by normoxic management during cardiopulmonary bypass. Gen Thorac Cardiovasc Surg 2012;60:549-56.
21. Ihnken K, Morita K, Buckberg GD. Delayed cardioplegic reoxygenation reduces reoxygenation injury in cyanotic immature hearts. Ann Thorac Surg 1998;66:177-82.
22. Manso PH, Carmona F, Dal-Pizzol F, Petronilho F, Cardoso F, Castro M et al. Oxidative stress markers are not associated with outcomes after pediatric heart surgery. Paediatr Anaesth 2013;23:188-94.
23. Chen Q, Yu W, Shi J, Shen J, Hu Y, Gao T et al. The effect of venovenous extra-corporeal membrane oxygenation (ECMO) therapy on immune inflammatory response of cerebral tissues in porcine model. J Cardiothorac Surg 2013;8:186.
24. Plötz FB, van Oeveren W, Bartlett RH, Wildevuur CR. Blood activation during neonatal extracorporeal life support. J Thorac Cardiovasc Surg 1993;105:823-32.
25. DeSilva RJ, Soto C, Spratt P. Extra corporeal membrane oxygenation as right heart support following left ventricular assist device placement: a new cannulation technique. Heart Lung Circ 2012;21:218-20.